8K7 — UG Healthcare Income Statement
0.000.00%
Last trade - 00:00- SG$63.63m
- SG$85.28m
- SG$144.07m
- 56
- 73
- 49
- 66
Annual income statement for UG Healthcare, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 338 | 233 | 101 | 115 | 144 |
| Cost of Revenue | |||||
| Gross Profit | 196 | 84.4 | 1.45 | 25.9 | 34.7 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 182 | 183 | 129 | 123 | 145 |
| Operating Profit | 156 | 49.5 | -28 | -7.73 | -1.22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 159 | 48.8 | -28.4 | -9.09 | -3.44 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 120 | 39.8 | -27 | -8.78 | -4.42 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 119 | 36.8 | -20.7 | -6.06 | -3.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 119 | 36.8 | -20.7 | -6.06 | -3.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.195 | 0.06 | -0.028 | -0.01 | -0.005 |
| Dividends per Share | |||||
| Special Dividends per Share |